M&A M&A
Aurobindo, Cadila, UPL in fray to acquire bankrupt Sterling Biotech
Aurobindo Pharma, Cadila Healthcare and UPL are among five companies in the race to acquire bankrupt Sterling Biotech through the liquidation process.
More in M&A
- Gas utility GAIL explores stake acquisition in LNG projects in US
- Healthium, Romsons in race to acquire medical devices seller BL Lifesciences
- Agri-trader NHC Foods to acquire 75% stake in Singapore’s DNR Ventures for $5.5 M
- FMCG co. Marico buys addnl 24% stake in Satiya Nutraceuticals for Rs.1,012-Cr